(Q45933327)

English

Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.

scientific article published on 10 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

author name string

Ayuko Nakano

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Yoshiyuki Hattori

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Chie Aoki

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Teruo Jojima

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Kikuo Kasai

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

publication date

10 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

32

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

765-769

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

https://scigraph.springernature.com/pub.10.1038/hr.2009.95

0 references

Atherosclerosis. the road ahead

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Therapeutic roles of peroxisome proliferator-activated receptor agonists

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2009.95

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19590508

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45933327&oldid=1456030639"